COMMUNIQUÉS West-GlobeNewswire

Rafael Pharmaceuticals Receives FDA Orphan Drug Designation for Treatment of Burkitt Lymphoma, and Initiates a Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia

28/06/2018 - 14:55

Newark, NJ, June 28, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has [...]

Devonian Announces the Signing of a Non-Binding Letter of Intent with Folia Biotech to develop FB-631 in cancer immunotherapy

28/06/2018 - 14:45

QUEBEC CITY, Quebec, June 28, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (" Devonian " or the " Corporation ") (TSX VENTURE:GSD) and Folia Biotech inc. (‘‘Folia’’) today announce the signing of a non-binding [...]

Groupe Santé Devonian annonce la signature d’une lettre d’intention non contraignante avec Folia Biotech pour le développement du FB-631 en immunothérapie pour le cancer

28/06/2018 - 14:45

QUÉBEC, Québec, 28 juin 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) a annoncé aujourd'hui la signature d'une lettre d'intention non contraignante (« lettre d [...]

Grandevo® CG and Venerate® CG for Pest Insect and Mite Control Cleared for Use on Cannabis by the Colorado, Oregon, Washington, Nevada, and Alaska Departments of Agriculture

28/06/2018 - 14:31

Grandevo® CG and Venerate® CG Are Effective Tools for Controlling Economically Damaging Mites and Insect Pests DAVIS, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a [...]

Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI® (palonosetron HCI) in the U.S.

28/06/2018 - 14:30

Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI ® (palonosetron HCI) in the U.S. Iselin, NJ, USA, June 28, 2018 – Helsinn Therapeutics (U.S.) Inc., the U.S. subsidiary of Helsinn, a Swiss [...]

Celsion Corporation Announces Strategic Loan Facility

28/06/2018 - 14:30

$10 Million Improvement to the Balance Sheet Provides Additional Seven Months of Operating Runway LAWRENCEVILLE, N.J., June 28, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or “the Company”), [...]

Corvus Pharmaceuticals Announces Publication of Preclinical Study Results Demonstrating CPI-444 Antitumor Activity as Monotherapy and in Combination with Anti-PD-1 Therapy in Cancer Immunology, Immunotherapy

28/06/2018 - 14:30

Research elucidated novel mechanisms of CPI-444 indicating broad effects on several checkpoints BURLINGAME, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage [...]

International Endeavors Offers Equipment to Licensed Marijuana Growers

28/06/2018 - 14:30

TEMECULA, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC:IDVV) offers an innovative cooperative program for licensed marijuana growers to make use of the Off Grid [...]

GTX Corp Launches 2 New GPS Trackers for Kids SmartSole Now Available in Size Small

28/06/2018 - 14:14

LOS ANGELES, June 28, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, announces today the launch of the GPS [...]

Actinium Announces New Clinical Trial to Study Effect of Actimab-A on Minimal Residual Disease in Postremission AML Patients

28/06/2018 - 14:00

Minimal Residual Disease is increasingly recognized as a primary driver of high AML relapse rate highlighting need for improved consolidation therapies Webcast to be held on July 10, 2018 at 8:00 AM ET to discuss [...]

Retrotope Receives FDA Clearance to Commence RT001 Phase 2/3 Clinical Trial in Patients with Infantile Neuroaxonal Dystrophy (INAD)

28/06/2018 - 14:00

Patient enrollment anticipated to start in July 2018 LOS ALTOS, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today that the U.S. Food and Drug Administration (FDA) has granted the company approval to [...]

BRACAnalysis® CDx Identifies Patients Who Respond to Lynparza® in SOLO-1 Study

28/06/2018 - 13:05

SALT LAKE CITY, June 28, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, today announced that the Company’s BRACAnalysis ® CDx test identified responders to [...]

Amfora Unveils Broad Initiative to Develop Crops with Enhanced Protein Content for Food and Feed

28/06/2018 - 14:15

SAN FRANCISCO, June 28, 2018 (GLOBE NEWSWIRE) -- Amfora Inc., a biotechnology company committed to improving the nutritional content of food and feed crops, today unveiled a major new program to develop crops with [...]

scPharmaceuticals Appoints Frederick Hudson to Board of Directors

28/06/2018 - 14:00

BURLINGTON, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of [...]

CLS Holdings USA Closes Acquisition of Oasis Cannabis

28/06/2018 - 14:00

Enters the Legalized Cannabis Market in Las Vegas, NV Currently Generating Approximately $850,000 per Month in Revenue LAS VEGAS, June 28, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH) “CLS,” a [...]

Cellectar Announces Expansion of Diffuse Large B-Cell Lymphoma Cohort in CLR 131 Phase 2 Trial

28/06/2018 - 14:00

Response rate in cohort exceeded pre-specified value MADISON, Wis., June 28, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, [...]

Flatiron Health CMO/CSO Joins CareDx Board of Directors

28/06/2018 - 14:00

Amy Abernethy adds clinical expertise and patient data insights to the CareDx Board BRISBANE, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the [...]

Zafgen Announces Pricing of Offering of Common Stock

28/06/2018 - 14:00

BOSTON, June 28, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary MetAP2 biology platform to develop novel therapies for patients affected by [...]

Cocrystal Pharma Commences Enrollment and Initiates Patient Dosing in Phase 2a Study Evaluating CC-31244 for the Treatment of HCV

28/06/2018 - 13:35

- Topline results from Phase 2a study expected to be announced before year end - ATLANTA, GA and BOTHELL, WA, June 28, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a [...]